Form 4 for NEO NEOGENOMICS INC
Accepted 2024-08-19 00:00:00 ET · period of report 2024-08-15 · accession 0001077183-24-000143 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-08-19 | 2024-08-15 | NEO | Smith Christopher M | CEO | F - Tax | $0.00 | -33.1K | 646.3K | -5% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-08-15 | F | D | 33,130 | $0.00 | 646,302 | D | — | — | (F1) Shares surrendered to NeoGenomics Inc. for retirement to satisfy the tax obligations in connection with the August 15, 2024 vesting of restricted stock. |